Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using virtual reality to help dialysis patients feel better

Official title: Does Virtual Reality Improve Symptom Burden in Dialysis Patients?

Run by University of Zurich · NCT06250582 · Data updated 2026-11-12

This study is testing if virtual reality sessions during dialysis can help patients feel better both physically and mentally.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich, Canton of Zurich)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedJuly 31, 2025
Study endsDecember 31, 2025
Registry record updatedApril 27, 2025
Trial IDNCT06250582 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who are undergoing thrice-weekly hemodialysis and can communicate in German or English.

Probably not a fit

Patients with epilepsy or those who are currently pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of virtual reality therapy in reducing symptom burden and improving mental wellbeing in patients undergoing hemodialysis. Over a month, participants will experience a 30-minute virtual reality session during each regular dialysis treatment, allowing them to act as their own control group in a crossover design. The study aims to address the physical and emotional challenges faced by dialysis patients, potentially enhancing their quality of life through immersive technology.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life for dialysis patients by alleviating their symptom burden.

How similar studies have gone: While the use of virtual reality in medical settings is gaining traction, this specific application in dialysis patients is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Older than 18 years;
* in treatment with thrice-weekly hemodialysis sessions;
* regular hemodialysis duration of three to five hours
* having no visual impairment
* having no acoustic deficit
* patient must be capable of speaking and understanding German or English
* no signs of cognitive impairment
* patient oriented in time and space
* being able to give informed consent as documented by signature

Exclusion Criteria:

* diagnosis of epilepsy
* current pregnancy

Where it's running

  • University Hospital Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

  • Principal investigator: David Blum, Prof. Dr. — University of Zurich
  • Study coordinator: David Blum, Prof.
  • Email: david.blum@usz.ch
  • Phone: +41432533742

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.